PAM Medical Plasma Limited Filleted accounts for Companies House (small and micro)

PAM MEDICAL PLASMA LIMITED - Company Information

false false false false false false false false false true false false false false false false false No description of principal activity 2017-07-01 Sage Accounts Production Advanced 2018 Update 1 - FRS 1,149 230 184 414 735 919 xbrli:pure xbrli:shares iso4217:GBP 10133369 2017-07-01 2018-06-30 10133369 2018-06-30 10133369 2017-06-30 10133369 2016-07-01 2017-06-30 10133369 2017-06-30 10133369 core:PlantMachinery 2017-07-01 2018-06-30 10133369 bus:Director1 2017-07-01 2018-06-30 10133369 core:WithinOneYear 2018-06-30 10133369 core:WithinOneYear 2017-06-30 10133369 core:PlantMachinery 2017-06-30 10133369 core:PlantMachinery 2018-06-30 10133369 core:ShareCapital 2018-06-30 10133369 core:ShareCapital 2017-06-30 10133369 core:RetainedEarningsAccumulatedLosses 2018-06-30 10133369 core:RetainedEarningsAccumulatedLosses 2017-06-30 10133369 core:PlantMachinery 2017-06-30 10133369 bus:SmallEntities 2017-07-01 2018-06-30 10133369 bus:AuditExemptWithAccountantsReport 2017-07-01 2018-06-30 10133369 bus:FullAccounts 2017-07-01 2018-06-30 10133369 bus:SmallCompaniesRegimeForAccounts 2017-07-01 2018-06-30 10133369 bus:PrivateLimitedCompanyLtd 2017-07-01 2018-06-30

COMPANY REGISTRATION NUMBER: 10133369

PAM MEDICAL PLASMA LIMITED

FILLETED UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED

30 June 2018

PAM MEDICAL PLASMA LIMITED

STATEMENT OF FINANCIAL POSITION

30 June 2018

	2018		2017
Note	£	£	£	£

FIXED ASSETS

Tangible assets	5		735		919

CURRENT ASSETS

Debtors	6	132,553	198,617
Cash at bank and in hand		165,950	111,809
		----------	----------
		298,503	310,426

CREDITORS: amounts falling due within one year	7	177,651		197,939
		----------		----------
NET CURRENT ASSETS			120,852		112,487
			----------		----------
TOTAL ASSETS LESS CURRENT LIABILITIES			121,587		113,406
			----------		----------
NET ASSETS			121,587		113,406
			----------		----------

CAPITAL AND RESERVES

Called up share capital	40	40
Profit and loss account	121,547	113,366
	----------	----------
SHAREHOLDERS FUNDS	121,587	113,406
	----------	----------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.

For the year ending 30 June 2018 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;

- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

PAM MEDICAL PLASMA LIMITED

STATEMENT OF FINANCIAL POSITION (continued)

30 June 2018

These financial statements were approved by the board of directors and authorised for issue on 17 January 2019 , and are signed on behalf of the board by:

C Fowler

Director

Company registration number: 10133369

PAM MEDICAL PLASMA LIMITED

NOTES TO THE FINANCIAL STATEMENTS

YEAR ENDED 30 JUNE 2018

1. GENERAL INFORMATION

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Bay 4 Block D, Willenhall Trading Estate, Midacre, Willenhall, WV13 2JW, England.

2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in compliance with FRS 102 Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

3. ACCOUNTING POLICIES

(a) Basis of preparation

The financial statements have been prepared on the historical cost basis. The financial statements are prepared in sterling, which is the functional currency of the entity. (b) Revenue recognition Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, stated net of discounts. (c) Current & deferred tax The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date. Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference. (d) Foreign currencies Foreign currency transactions are initially recorded in the functional currency, by applying the spot exchange rate as at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the exchange rate ruling at the reporting date, with any gains or losses being taken to the profit and loss account. (e) Tangible assets Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. (f) Depreciation Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

	Plant and machinery	-	20% reducing balance

(g) Impairment of fixed assets A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.

4. EMPLOYEE NUMBERS

The average number of persons employed by the company during the year amounted to 4 (2017:4).

5. TANGIBLE ASSETS

	Plant and machinery
	£
Cost
At 1 July 2017 and 30 June 2018	1,149
	-------
Depreciation
At 1 July 2017	230
Charge for the year	184
	-------
At 30 June 2018	414
	-------
Carrying amount
At 30 June 2018	735
	-------
At 30 June 2017	919
	-------

6. DEBTORS

	2018	2017
	£	£
Trade debtors	132,553	198,617
	----------	----------

7. CREDITORS: amounts falling due within one year

	2018	2017
	£	£
Trade creditors	72,084	87,288
Accruals and deferred income	3,950	2,160
Corporation tax	89,617	96,491
Other creditors	12,000	12,000
	----------	----------
	177,651	197,939
	----------	----------